Journal of Clinical Densitometry
Volume 13, Issue 4 , Pages 399-406 , October 2010

Dual-Energy X-ray Absorptiometry With Serum Ferritin Predicts Liver Iron Concentration and Changes in Concentration Better Than Ferritin Alone

  • John A. Shepherd

      Affiliations

    • Department of Radiology and Biomedical Imaging, University of California at San Francisco, San Francisco, CA, USA
    • Corresponding Author InformationAddress correspondence to: John A. Shepherd, PhD, Department of Radiology and Biomedical Imaging, University of California at San Francisco, 1635 Divisadero Street, Suite 525, San Francisco, CA 94115.
    • ,
  • Bo Fan

      Affiliations

    • Department of Radiology and Biomedical Imaging, University of California at San Francisco, San Francisco, CA, USA
    • ,
  • Ying Lu

      Affiliations

    • Department of Radiology and Biomedical Imaging, University of California at San Francisco, San Francisco, CA, USA
    • ,
  • Lorena Marquez

      Affiliations

    • Department of Radiology and Biomedical Imaging, University of California at San Francisco, San Francisco, CA, USA
    • ,
  • Khaled Salama

      Affiliations

    • Department of Pediatrics, University of Cairo, Cairo, Egypt
    • ,
  • Jimmy Hwang

      Affiliations

    • Department of Radiology and Biomedical Imaging, University of California at San Francisco, San Francisco, CA, USA
    • ,
  • Ellen B. Fung

      Affiliations

    • Children's Hospital Oakland Research Institute, Oakland, CA, USA

Received 18 November 2009 ,Revised 3 May 2010 ,Accepted 4 May 2010.

References 

  1. Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet. 1989;2(8653):27–30
  2. Borgna-Pignatti C, Cappellini MD, De Stefano P, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054:40–47
  3. Fung EB, Harmatz PR, Milet M, et al. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions. Transfusion. 2008;48(9):1971–1980
  4. Vogiatzi MG, Macklin EA, Fung EB, et al. Prevalence of fractures among the Thalassemia syndromes in North America. Bone. 2006;38(4):571–575
  5. Bishop N, Braillon P, Burnham J, et al. Dual-energy X-ray absorptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD Pediatric Official Positions. J Clin Densitom. 2008;11(1):29–42
  6. Borgna-Pignatti C, Castriota-Scanderbeg A. Methods for evaluating iron stores and efficacy of chelation in transfusional hemosiderosis. Haematologica. 1991;76(5):409–413
  7. Brittenham GM, Cohen AR, McLaren CE, et al. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol. 1993;42(1):81–85
  8. Pakbaz Z, Fischer R, Fung E, et al. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer. 2007;49(3):329–332
  9. Harmatz P, Butensky E, Quirolo K, et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood. 2000;96(1):76–79
  10. Telfer PT, Prestcott E, Holden S, et al. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol. 2000;110(4):971–977
  11. Houang MT, Arozena X, Skalicka A, et al. Correlation between computed tomographic values and liver iron content in thalassaemia major with iron overload. Lancet. 1979;1(8130):1322–1323
  12. St Pierre TG, Clark PR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood. 2005;105(2):855–861
  13. Brittenham GM, Badman DG. Noninvasive measurement of iron: report of an NIDDK workshop. Blood. 2003;101(1):15–19
  14. Chatterton BE, Thomas CM, Schultz CG. Liver density measured by DEXA correlates with serum ferritin in patients with beta-Thalassemia Major. J Clin Densitom. 2003;6(3):283–288
  15. Fung EB, Fischer R, Pakbaz Z, et al. The new SQUID biosusceptometer at Oakland: first year of experience. Neurol Clin Neurophysiol. 2004;2004:5
  16. Fischer R, Tiemann CD, Engelhardt R, Nielsen P, Dürken M, Gabbe EE, et al. Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Am J Heme. 1999;60:289–299
  17. Fischer R. Liver iron susceptometry. In:  Andrae W,  Nowak H editor. Magnetism in Medicine—A Handbook. Berlin, Germany: Wiley-VCH; 1998;p. 286–301
  18. Brittenham GM, Farrell DE, Harris JW, et al. Magnetic-susceptibility measurement of human iron stores. N Engl J Med. 1982;307(27):1671–1675
  19. Fischer R, Engelhardt R, Nielsen P, et al. Liver iron quantification in the diagnosis and therapy control of iron overload patients. In:  Hoke M,  Erne S,  Okada Y, et al. editor. Advances in Biomagnetism: Clinical Aspects. Amsterdam, The Netherlands: Elsevier; 1992;p. 585–588
  20. Dresner Pollack R, Rachmilewitz E, Blumenfeld A, et al. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol. 2000;111(3):902–907
  21. Vogiatzi MG, Autio KA, Schneider R, Giardina PJ. Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis of low bone mass in thalassemia. J Pediatr Endocrinol Metab. 2004;17(10):1415–1421
  22. Di Stefano M, Chiabotto P, Roggia C, et al. Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugs. J Bone Miner Metab. 2004;22(1):53–57
  23. Origa R, Galanello R, Ganz T, et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica. 2007;92(5):583–588
  24. Origa R, Fiumana E, Gamberini MR, et al. Osteoporosis in beta-thalassemia: clinical and genetic aspects. Ann N Y Acad Sci. 2005;1054:451–456
  25. Vogiatzi MG, Macklin EA, Fung EB, et al. Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res. 2009;24(3):543–557
  26. Nielsen P, Gunther U, Durken M, et al. Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance. J Lab Clin Med. 2000;135(5):413–418
  27. Angelucci E, Barosi G, Camaschella C, et al. Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Haematologica. 2008;93(5):741–752
  28. Vichinsky E, Levine L, Bhatia S, et al. Standards of care guidelines for thalassemia. In:  Levine M editors. Oakland, CA: Children's Hospital & Research Center Oakland; 2008;http://www.thalassemia.com/SOC_guidelines.html. Accessed June 20, 2010
  29. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171–2179
  30. Genant HK, Grampp S, Gluer CC, et al. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res. 1994;9(10):1503–1514

PII: S1094-6950(10)00191-5

doi: 10.1016/j.jocd.2010.05.003

Journal of Clinical Densitometry
Volume 13, Issue 4 , Pages 399-406 , October 2010

Article Tools

* Image Usage & Resolution